Serum KL-6 Could Represent a Reliable Indicator of Unfavourable Outcome in Patients with COVID-19 Pneumonia

KL-6 is a sialoglycoprotein antigen which proved elevated in the serum of patients with different interstitial lung diseases, especially in those with a poorer outcome. Given that interstitial pneumonia is the most common presentation of SARS-CoV2 infection, we evaluated the prognostic role of KL-6...

Descripción completa

Detalles Bibliográficos
Autores principales: Scotto, Riccardo, Pinchera, Biagio, Perna, Francesco, Atripaldi, Lidia, Giaccone, Agnese, Sequino, Davide, Zappulo, Emanuela, Sardanelli, Alessia, Schiano Moriello, Nicola, Stanziola, Anna, Bocchino, Marialuisa, Gentile, Ivan, Sanduzzi, Alessandro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7924557/
https://www.ncbi.nlm.nih.gov/pubmed/33672761
http://dx.doi.org/10.3390/ijerph18042078

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7924557/
https://www.ncbi.nlm.nih.gov/pubmed/33672761
http://dx.doi.org/10.3390/ijerph18042078

Ejemplares similares